Yang Zhao Selected Research

Tyrosine Kinase Inhibitors

6/2024	Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
2/2022	Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters.
1/2022	Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasis.
11/2021	Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain Metastases.
1/2021	c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma.
12/2020	Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors.
12/2020	A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player.
1/2020	Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: a surveillance, epidemiology and end results (SEER) analysis.
11/2018	Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
1/2017	Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang Zhao Research Topics

Disease

408	Neoplasms (Cancer) 05/2024 - 03/2008
86	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2006
62	Inflammation (Inflammations) 04/2024 - 11/2010
59	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2008
50	Carcinogenesis 06/2023 - 04/2010
41	Infections 02/2024 - 03/2009
37	Pain (Aches) 02/2024 - 11/2010
36	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 12/2009
36	Hypertension (High Blood Pressure) 10/2023 - 01/2013
34	Hepatocellular Carcinoma (Hepatoma) 06/2024 - 11/2002
33	Type 2 Diabetes Mellitus (MODY) 08/2023 - 07/2007
32	COVID-19 03/2024 - 01/2020
31	Lung Neoplasms (Lung Cancer) 02/2024 - 02/2010
29	Carcinoma (Carcinomatosis) 05/2024 - 07/2011
26	Hypoxia (Hypoxemia) 02/2024 - 06/2013
26	Stomach Neoplasms (Stomach Cancer) 01/2024 - 04/2008
26	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 03/2006
26	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 03/2010
21	Body Weight (Weight, Body) 01/2024 - 01/2010
21	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 03/2015
20	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2010
19	Insulin Resistance 04/2024 - 07/2010
19	Obesity 12/2023 - 06/2009
18	Fibrosis (Cirrhosis) 02/2024 - 02/2012
18	Wounds and Injuries (Trauma) 11/2023 - 02/2013
16	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 06/2009
16	Ischemia 11/2023 - 01/2013
16	Ovarian Epithelial Carcinoma 01/2018 - 10/2009
15	Osteoarthritis 02/2024 - 04/2011
15	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 01/2016
14	Stroke (Strokes) 04/2024 - 02/2017
14	Parkinson Disease (Parkinson's Disease) 10/2023 - 01/2016
13	Sepsis (Septicemia) 04/2024 - 11/2012
13	Major Depressive Disorder (Major Depressive Disorders) 12/2023 - 12/2010
12	Reperfusion Injury 04/2024 - 08/2014
12	Adenocarcinoma of Lung 12/2023 - 04/2010
12	Neuralgia (Stump Neuralgia) 01/2022 - 11/2010
11	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 09/2015
11	Hemorrhage 02/2024 - 02/2012
11	Myocardial Infarction 12/2023 - 08/2015
11	Atherosclerosis 10/2023 - 09/2009
11	Necrosis 10/2023 - 01/2015
11	Liver Neoplasms (Liver Cancer) 04/2023 - 10/2017
11	Adenocarcinoma 01/2023 - 01/2012
10	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 06/2013
10	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 11/2013
10	Coronary Disease (Coronary Heart Disease) 04/2024 - 02/2006
10	Hypersensitivity (Allergy) 01/2024 - 01/2010
10	Cognitive Dysfunction 10/2023 - 06/2012
10	Cataract (Cataracts) 05/2022 - 09/2016
9	Triple Negative Breast Neoplasms 03/2024 - 01/2018

Drug/Important Bio-Agent (IBA)

136	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2005
92	Biomarkers (Surrogate Marker)IBA 02/2024 - 04/2008
47	MicroRNAs (MicroRNA)IBA 01/2024 - 04/2010
44	Messenger RNA (mRNA)IBA 12/2023 - 03/2008
33	CytokinesIBA 01/2024 - 06/2011
29	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 12/2012
28	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2014
27	Long Noncoding RNAIBA 03/2024 - 01/2014
22	Immune Checkpoint InhibitorsIBA 06/2024 - 09/2017
22	LipidsIBA 01/2024 - 06/2011
22	EnzymesIBA 11/2023 - 09/2009
19	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2012
18	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2024 - 03/2010
18	Therapeutic UsesIBA 01/2024 - 11/2016
18	Transcription Factors (Transcription Factor)IBA 01/2023 - 05/2012
17	Circular RNAIBA 07/2023 - 01/2017
17	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2012 - 11/2010
16	Triglycerides (Triacylglycerol)IBA 04/2024 - 01/2017
14	Paclitaxel (Taxol)FDA LinkGeneric 03/2023 - 03/2012
14	Small Interfering RNA (siRNA)IBA 01/2018 - 03/2010
13	Phosphotransferases (Kinase)IBA 03/2024 - 03/2010
13	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 03/2008
13	ErbB Receptors (EGF Receptor)IBA 01/2023 - 03/2014
13	ORALIT (ORS)IBA 01/2022 - 10/2010
13	Peptides (Polypeptides)IBA 01/2022 - 10/2009
12	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2014
12	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 05/2009
12	CateninsIBA 09/2023 - 06/2013
12	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2008
11	Neuroprotective AgentsIBA 03/2024 - 01/2018
11	Insulin (Novolin)FDA Link 01/2024 - 01/2013
11	Adenosine Triphosphate (ATP)IBA 12/2023 - 03/2008
11	Oxygen (Dioxygen)IBA 12/2023 - 09/2014
11	LigandsIBA 12/2023 - 12/2015
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2012
11	AntigensIBA 01/2023 - 07/2011
11	Opioid Analgesics (Opioids)IBA 01/2023 - 12/2010
11	Estrogen ReceptorsIBA 05/2022 - 02/2013
10	Tyrosine Kinase InhibitorsIBA 06/2024 - 01/2017
10	CholesterolIBA 02/2023 - 05/2015
10	secukinumabIBA 01/2023 - 04/2016
9	CollagenIBA 04/2024 - 03/2010
9	Cyclin D1IBA 03/2024 - 03/2006

Therapy/Procedure

153	Therapeutics 03/2024 - 06/2006
49	Drug Therapy (Chemotherapy) 02/2024 - 04/2010
30	Immunotherapy 04/2024 - 01/2017
20	Radiotherapy 12/2023 - 01/2013
19	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2023 - 03/2014
11	Ligation 09/2023 - 02/2012